DuBridge RB - Search Results

1

COBRA™: a highly potent conditionally active T cell engager engineered for the treatment of solid tumors.

Panchal A, Seto P, Wall R, Hillier BJ, Zhu Y, Krakow J, Datt A, Pongo E, Bagheri A, Chen TT, Degenhardt JD, Culp PA, Dettling DE, Vinogradova MV, May C, DuBridge RB. Panchal A, et al. Among authors: dubridge rb. MAbs. 2020 Jan-Dec;12(1):1792130. doi: 10.1080/19420862.2020.1792130. MAbs. 2020. PMID: 32684124 Free PMC article.

2

Regression of EGFR positive established solid tumors in mice with the conditionally active T cell engager TAK-186.

Dettling DE, Kwok E, Quach L, Datt A, Degenhardt JD, Panchal A, Seto P, Krakow JL, Wall R, Hillier BJ, Zhu Y, Vinogradova M, DuBridge RB, May C. Dettling DE, et al. Among authors: dubridge rb. J Immunother Cancer. 2022 Jun;10(6):e004336. doi: 10.1136/jitc-2021-004336. J Immunother Cancer. 2022. PMID: 35728872 Free PMC article.

3

Structural arrangement of the VH and VL domains in the COBRA™ T-cell engaging single-chain diabody.

Krakow J, Hammel M, Zhu Y, Hillier BJ, Paolella B, Desmarais A, Wall R, Chen TT, Pei R, Karunatilake C, DuBridge R, Vinogradova M. Krakow J, et al. Antib Ther. 2021 Dec 16;5(1):1-10. doi: 10.1093/abt/tbab028. eCollection 2022 Jan. Antib Ther. 2021. PMID: 35005430 Free PMC article.

4

TriTACs, a Novel Class of T-Cell-Engaging Protein Constructs Designed for the Treatment of Solid Tumors.

Austin RJ, Lemon BD, Aaron WH, Barath M, Culp PA, DuBridge RB, Evnin LB, Jones A, Panchal A, Patnaik P, Ramakrishnan V, Rocha SS, Seto P, Sexton K, Strobel KL, Wall R, Yu S, Yu TZ, Law CL, Baeuerle PA, Wesche H. Austin RJ, et al. Among authors: dubridge rb. Mol Cancer Ther. 2021 Jan;20(1):109-120. doi: 10.1158/1535-7163.MCT-20-0061. Epub 2020 Nov 17. Mol Cancer Ther. 2021. PMID: 33203731

5

CRISPR/Cas9 disruption of EpCAM Exon 2 results in cell-surface expression of a truncated protein targeted by an EpCAM specific T cell engager.

Bagheri A, Culp PA, DuBridge RB, Chen TT. Bagheri A, et al. Among authors: dubridge rb. Biochem Biophys Rep. 2022 Jan 12;29:101205. doi: 10.1016/j.bbrep.2022.101205. eCollection 2022 Mar. Biochem Biophys Rep. 2022. PMID: 35071801 Free PMC article.

6

Antibodies to TWEAK receptor inhibit human tumor growth through dual mechanisms.

Culp PA, Choi D, Zhang Y, Yin J, Seto P, Ybarra SE, Su M, Sho M, Steinle R, Wong MH, Evangelista F, Grove J, Cardenas M, James M, Hsi ED, Chao DT, Powers DB, Ramakrishnan V, Dubridge R. Culp PA, et al. Clin Cancer Res. 2010 Jan 15;16(2):497-508. doi: 10.1158/1078-0432.CCR-09-1929. Epub 2010 Jan 12. Clin Cancer Res. 2010. PMID: 20068083

7

A function blocking anti-mouse integrin alpha5beta1 antibody inhibits angiogenesis and impedes tumor growth in vivo.

Bhaskar V, Zhang D, Fox M, Seto P, Wong MH, Wales PE, Powers D, Chao DT, Dubridge RB, Ramakrishnan V. Bhaskar V, et al. Among authors: dubridge rb. J Transl Med. 2007 Nov 27;5:61. doi: 10.1186/1479-5876-5-61. J Transl Med. 2007. PMID: 18042290 Free PMC article.

8

The immunogenicity of humanized and fully human antibodies: residual immunogenicity resides in the CDR regions.

Harding FA, Stickler MM, Razo J, DuBridge RB. Harding FA, et al. Among authors: dubridge rb. MAbs. 2010 May-Jun;2(3):256-65. doi: 10.4161/mabs.2.3.11641. Epub 2010 May 1. MAbs. 2010. PMID: 20400861 Free PMC article.

9

Deep mutational scanning of an antibody against epidermal growth factor receptor using mammalian cell display and massively parallel pyrosequencing.

Forsyth CM, Juan V, Akamatsu Y, DuBridge RB, Doan M, Ivanov AV, Ma Z, Polakoff D, Razo J, Wilson K, Powers DB. Forsyth CM, et al. Among authors: dubridge rb. MAbs. 2013 Jul-Aug;5(4):523-32. doi: 10.4161/mabs.24979. Epub 2013 May 29. MAbs. 2013. PMID: 23765106 Free PMC article.

10

E-selectin up-regulation allows for targeted drug delivery in prostate cancer.

Bhaskar V, Law DA, Ibsen E, Breinberg D, Cass KM, DuBridge RB, Evangelista F, Henshall SM, Hevezi P, Miller JC, Pong M, Powers R, Senter P, Stockett D, Sutherland RL, von Freeden-Jeffry U, Willhite D, Murray R, Afar DE, Ramakrishnan V. Bhaskar V, et al. Among authors: dubridge rb. Cancer Res. 2003 Oct 1;63(19):6387-94. Cancer Res. 2003. PMID: 14559828

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

25 results

Search Page